LearnGlossaryMarketStocksSuperinvestorsSign in

IART

Integra LifeSciences Holdings Corporation

Healthcare · $1.3B market cap

Verdict

We can't put a fair value on IART right now. Our value came out at less than a tenth of the share price. When our answer is that far from the market, the method most likely doesn't fit this company, so we don't publish a number.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth8.5% a year✗
Equity per share growth8.1% a year✗
Sales growth6.5% a year✗
Free cash flow growth6.2% a year✗
Return on invested capital1.6%✗

Follow IART

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

None of the investors we track holds IART right now. In Q2 2026, 1 sold out. Who we track

Moves in Q2 2026

Sold out: Lee Ainslie

Insider activity

Since Sep 1, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

Veillon-Berteloot Chantal

EVP & CHRO · 2026-09-01

Tax withholding

$24K

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works